Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Canada (1)
Advocacy (policy advocacy, lobbying)
Regulatory Body (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Roles and responsibilities
Clinical study phase I